Navigation Links
Caraco Pharmaceutical Laboratories, Ltd. to Announce Fourth Quarter and Fiscal Year 2008 Results on May 29, 2008
Date:5/20/2008

DETROIT, May 20 /PRNewswire-FirstCall/ -- Caraco Pharmaceutical Laboratories, Ltd. (Amex: CPD) announced that the Company will release results for its fourth quarter and fiscal year 2008 ended March 31, 2008, prior to the market opening on Thursday May 29, 2008.

Detroit-based Caraco Pharmaceutical Laboratories, Ltd., develops, manufactures, markets and distributes generic and private-label pharmaceuticals to the nation's largest wholesalers, distributors, drugstore chains and managed care providers.

Safe Harbor: This news release contains forward-looking statements made pursuant to the safe-harbor provisions of the Private Securities Litigation Reform Act of 1995. Such statements are based on management's current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those described in the forward- looking statements. These risks and uncertainties are contained in the Corporation's filings with the Securities and Exchange Commission and include, but are not limited to: information of a preliminary nature that may be subject to adjustment, potentially not obtaining or delay in obtaining FDA approval for new products, governmental restrictions on the sale of certain products, development by competitors of new or superior products or cheaper products or new technology for the production of products, the entry into the market of new competitors, market and customer acceptance and demand for new pharmaceutical products, availability of raw materials, timing and success of product development and launches, dependence on few products generating majority of sales, product liability claims for which the Company may be inadequately insured, and other risks identified in this re
'/>"/>

SOURCE Caraco Pharmaceutical Laboratories, Ltd.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Caraco Pharmaceutical Laboratories Ltd. Wins Summary Judgment on Generic Ultracet(R)
2. Caraco Pharmaceutical Laboratories Ltd. To Market Generic Ethyol(R)
3. Caraco Pharmaceutical Laboratories Ltd. to Market Generic Protonix(R)
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Metaglip(R)
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Norvasc(R)
8. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lexapro(R)
9. Caraco Pharmaceutical Laboratories, Ltd. Announces Tentative FDA Approval for Generic Lamictal(R)
10. Caraco Pharmaceutical Laboratories Ltd. Reports Record Net Sales for the Second Quarter and First Six Months of Fiscal 2008
11. Caraco Pharmaceutical Laboratories Ltd. Announces Tentative FDA Approval for Generic Zyrtec Chewable(R)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)... are recruited annually to participate in clinical...ch Protection (AHRP), and most will be compensated...tions view payments to volunteers as compensation ...ential risks related to participating in the exper...e a very different view of clinical trial compensa...
(Date:12/4/2009)...it consumption leads to success, study finds , ...reased exercise, reduced soda consumption and self...rol strategies for adolescents, a new study shows....heir weight-control strategies and lifestyle habit... had not. The responses were grouped into four cat...
(Date:12/4/2009)...r at-risk patient groups , , FRIDAY, Dec...rticularly Ewing sarcomas and central nervous syst... researchers have found. , The study authors an... most common pediatric cancers who were enrolled i...searchers found that the overall cancer recurrence...
(Date:12/4/2009)...y hesitate to take breast cancer drug, study finds...Worries about side effects are a major reason why ...breast cancer are willing to take the drug tamoxif... In an effort to inform women about the risks and ...ty of Michigan Comprehensive Cancer Center created...
(Date:12/4/2009)...la., Dec. 4 Today, seven of Florid...in improving the health of Florida,s uninsured and...Florida,s 2009 Sapphire Award ceremony. ,, The ...hat recognizes and promotes organizations that hav...parities within their communities. ,, Honorees ...
Breaking Medicine News(10 mins):Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:High-Risk Women May Often Avoid Using Tamoxifen 2Health News:Top Nonprofits Honored for Improving Health of Floridians 2Health News:Top Nonprofits Honored for Improving Health of Floridians 3
...tional AIDS Vaccine Initiative (IAVI) together wit...have announced a public-private partnership to dev...uman primate adenovirus vector technology was deri...GSK. According to the agreement, IAVI and GS...
...vening the U.S. Food and Drug Administration order...beling as several cases have been reported to caus...ed that all consumers should stop taking impotency...s. This move was followed by an announcemen...
... provide quick relief from post pregnancy depressi...women who may be more vulnerable to this type of d...he condition. However a recent study by the resear... depression but the treatment meted out to the pre...
...h teams working independently have identified how ...lls to cause infections. Hendra virus belongs...wn to cause an outbreak of respiratory and neurolo...s, mostly in men. Researchers have found that...
...hod to reduce the risk of deaths from advanced pro... method of screening. A recent study suggests that...aths. Prostate cancer is the most frequently ...ady spread to other organs. PSA blood test is a si...
... of two human clinical trials support the enhance...ges using its novel technology which will interest... its bioavailability, or the body's absorption of ...e emulsifiers and solvents to trap water droplets ...
Other Medicine News:Health News:Developing a new vaccine using a new technology 2Health News:Screening For Prostate Cancer May Reduce Mortality Rate 2
(Date:12/4/2009)...wswire-FirstCall/ -- The U.S. Food and Drug Admi...nzapine) in tablet form as an option for the treat...associated with bipolar I disorder in adolescents ...abel states that clinicians should take into consi...nd hyperlipidemia in adolescents compared to adult...
(Date:12/4/2009)...PRNewswire-FirstCall/ -- Onyx Pharmaceuticals, Inc...st an investor teleconference and webcast. Princi...ons surrounding carfilzomib in relapsed and/or ref...American Society of Hematology (ASH) Annual Meetin.... CT/10:00 a.m. ET on Monday, December 7, 2009. T...
(Date:12/4/2009)...4 Chemistry World rec... Pharmaceutical Research and Manufacturers of Amer...ccines in development for HIV/AIDS and related con...roducts in development include 23 vaccines and 54 ...al trials or awaiting approval by the U.S. Food an...
Breaking Medicine Technology:FDA Approves Lilly's Zyprexa for Two Adolescent Indications 2FDA Approves Lilly's Zyprexa for Two Adolescent Indications 3FDA Approves Lilly's Zyprexa for Two Adolescent Indications 4FDA Approves Lilly's Zyprexa for Two Adolescent Indications 5FDA Approves Lilly's Zyprexa for Two Adolescent Indications 6FDA Approves Lilly's Zyprexa for Two Adolescent Indications 7Onyx Pharmaceuticals to Host American Society of Hematology (ASH) Investor Teleconference 2U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 1Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 2Emerging Evidence Shows Strawberries Can Help Lower Cholesterol 58884 3Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 1Empire BlueCross BlueShield to Support 2011 World Police 26amp 3B Fire Games in NYC 58880 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 1The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 2The ZigBee Alliance and Continua Health Alliance Collaborate to Expand Telehealth Capabilities 5232 3
HCS INTERACTANT Application Financial System Solutions
Infinity Amylase CNPG3 (Liquid)
Infinity Uric Acid (Powder)
...owder reagent once reconstituted offers the labora...y to help maximize laboratory productivity, minimi...und time. The proprietary technology of the Infini...elf life and stability once reconstituted that wil...
Medicine Products: